14 July 2016Americas
Illumina to pay Enzo $21m to end patent dispute
Illumina has reached a settlement with Enzo Life Sciences, bringing an end to allegations that it infringed a DNA detection patent.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
7 January 2016 Enzo Biochem has agreed a $9 million settlement with Agilent Technologies in a patent infringement lawsuit centring on technology used in detecting nucleic acid.
Europe
8 September 2017 Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.
Editor's picks
Editor's picks
Americas
7 January 2016 Enzo Biochem has agreed a $9 million settlement with Agilent Technologies in a patent infringement lawsuit centring on technology used in detecting nucleic acid.
Europe
8 September 2017 Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.
Americas
7 January 2016 Enzo Biochem has agreed a $9 million settlement with Agilent Technologies in a patent infringement lawsuit centring on technology used in detecting nucleic acid.
Europe
8 September 2017 Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.